Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2021

Feb 25, 2021

30016_dirs_2021-02-25_1dca0854-08cc-4ba4-b7ad-1d8ddaaf94e5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2021-02-23

Reporting Person: AYERS JONATHAN W (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-02-23 Common Stock M 1476 $67.85 Acquired 654213 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-02-23 Incentive Stock Option (right-to-buy) $67.85 M 1476 Disposed 2026-02-13 Common Stock (1476) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 10000 Indirect

Footnotes

F1: Grant of option to buy shares of Issuer common stock that became exercisable in one installment on February 14, 2021.

F2: Not applicable.